110 related articles for article (PubMed ID: 19072644)
1. Germline epimutation in humans.
Cropley JE; Martin DI; Suter CM
Pharmacogenomics; 2008 Dec; 9(12):1861-8. PubMed ID: 19072644
[TBL] [Abstract][Full Text] [Related]
2. Germline epimutation: A basis for epigenetic disease in humans.
Martin DI; Ward R; Suter CM
Ann N Y Acad Sci; 2005; 1054():68-77. PubMed ID: 16339653
[TBL] [Abstract][Full Text] [Related]
3. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer.
Hitchins MP; Ward RL
J Med Genet; 2009 Dec; 46(12):793-802. PubMed ID: 19564652
[TBL] [Abstract][Full Text] [Related]
4. Heritable germline epimutation is not the same as transgenerational epigenetic inheritance.
Chong S; Youngson NA; Whitelaw E
Nat Genet; 2007 May; 39(5):574-5; author reply 575-6. PubMed ID: 17460682
[No Abstract] [Full Text] [Related]
5. Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility.
Hitchins MP
Adv Genet; 2010; 70():201-43. PubMed ID: 20920750
[TBL] [Abstract][Full Text] [Related]
6. Germline epimutation of MLH1 in individuals with multiple cancers.
Suter CM; Martin DI; Ward RL
Nat Genet; 2004 May; 36(5):497-501. PubMed ID: 15064764
[TBL] [Abstract][Full Text] [Related]
7. MLH1 germline epimutations in selected patients with early-onset non-polyposis colorectal cancer.
Valle L; Carbonell P; Fernandez V; Dotor AM; Sanz M; Benitez J; Urioste M
Clin Genet; 2007 Mar; 71(3):232-7. PubMed ID: 17309645
[TBL] [Abstract][Full Text] [Related]
8. MLH1 methylation screening is effective in identifying epimutation carriers.
Pineda M; Mur P; Iniesta MD; Borràs E; Campos O; Vargas G; Iglesias S; Fernández A; Gruber SB; Lázaro C; Brunet J; Navarro M; Blanco I; Capellá G
Eur J Hum Genet; 2012 Dec; 20(12):1256-64. PubMed ID: 22763379
[TBL] [Abstract][Full Text] [Related]
9. Inherited epimutation or a haplotypic basis for the propensity to silence?
Suter CM; Martin DI
Nat Genet; 2007 May; 39(5):573; author reply 576. PubMed ID: 17460681
[No Abstract] [Full Text] [Related]
10. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.
Hitchins MP
Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015
[TBL] [Abstract][Full Text] [Related]
11. [Germ-line epimutations and human cancer].
Wu PY; Fan YM; Wang YP
Ai Zheng; 2009 Dec; 28(12):1236-42. PubMed ID: 19958615
[TBL] [Abstract][Full Text] [Related]
12. Inheritance of a cancer-associated MLH1 germ-line epimutation.
Hitchins MP; Wong JJ; Suthers G; Suter CM; Martin DI; Hawkins NJ; Ward RL
N Engl J Med; 2007 Feb; 356(7):697-705. PubMed ID: 17301300
[TBL] [Abstract][Full Text] [Related]
13. Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5'UTR.
Hitchins MP; Rapkins RW; Kwok CT; Srivastava S; Wong JJ; Khachigian LM; Polly P; Goldblatt J; Ward RL
Cancer Cell; 2011 Aug; 20(2):200-13. PubMed ID: 21840485
[TBL] [Abstract][Full Text] [Related]
14. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.
Rahner N; Friedrichs N; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
J Pathol; 2008 Jan; 214(1):10-6. PubMed ID: 17973250
[TBL] [Abstract][Full Text] [Related]
15. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.
Morak M; Schackert HK; Rahner N; Betz B; Ebert M; Walldorf C; Royer-Pokora B; Schulmann K; von Knebel-Doeberitz M; Dietmaier W; Keller G; Kerker B; Leitner G; Holinski-Feder E
Eur J Hum Genet; 2008 Jul; 16(7):804-11. PubMed ID: 18301449
[TBL] [Abstract][Full Text] [Related]
16. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH
Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation, epimutations and cancer predisposition.
Dobrovic A; Kristensen LS
Int J Biochem Cell Biol; 2009 Jan; 41(1):34-9. PubMed ID: 18835361
[TBL] [Abstract][Full Text] [Related]
18. Re: Rahner et al. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome. J Pathol 2008; 214: 10-16.
Lehmann U
J Pathol; 2008 May; 215(1):97; author reply 98. PubMed ID: 18335486
[No Abstract] [Full Text] [Related]
19. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
Alemayehu A; Sebova K; Fridrichova I
Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
[TBL] [Abstract][Full Text] [Related]
20. Diversity of genetic events associated with MLH1 promoter methylation in Lynch syndrome families with heritable constitutional epimutation.
Leclerc J; Flament C; Lovecchio T; Delattre L; Ait Yahya E; Baert-Desurmont S; Burnichon N; Bronner M; Cabaret O; Lejeune S; Guimbaud R; Morin G; Mauillon J; Jonveaux P; Laurent-Puig P; Frébourg T; Porchet N; Buisine MP
Genet Med; 2018 Dec; 20(12):1589-1599. PubMed ID: 29790873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
